开云app官网登录入口网页版-官方正版

#晚期肺癌#

40篇内容 | 1588人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2194689, encodeId=ac532194689b8, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=European Radiology：预测晚期非小细胞肺癌患者消融后无进展生存的预后模型, objectType=article, longId=817691, objectId=8bc381e691ee, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867513815_4754896.png, objectUrl=/article/show_article.do?id=8bc381e691ee, replyNumber=0, likeNumber=50, createdTime=2024-03-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8bc381e691ee, moduleTitle=European Radiology：预测晚期非小细胞肺癌患者消融后无进展生存的预后模型, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8bc381e691ee)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1630963, encodeId=47ab163096364, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=【今晚直播】局部晚期肺癌基于分子分期和分子分型的“个体化”MDT治疗策略, objectType=article, longId=736155, objectId=6d55e3615518, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d55e3615518, replyNumber=0, likeNumber=52, createdTime=2022-08-19, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d55e3615518, moduleTitle=【今晚直播】局部晚期肺癌基于分子分期和分子分型的“个体化”MDT治疗策略, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6d55e3615518)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630962, encodeId=b8331630962ca, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=ASCO发布2022版肺癌诊治指南：晚期肺癌一线、二线、三线治疗全汇总！, objectType=article, longId=733743, objectId=f186e3374335, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f186e3374335, replyNumber=0, likeNumber=61, createdTime=2022-07-30, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f186e3374335, moduleTitle=ASCO发布2022版肺癌诊治指南：晚期肺癌一线、二线、三线治疗全汇总！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f186e3374335)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630961, encodeId=fff216309617d, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=Front Oncol：既往接受过抗血管治疗可能影响后线安罗替尼治疗晚期肺癌的PFS，但不影响OS和ORR, objectType=article, longId=292663, objectId=79a729266362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79a729266362, replyNumber=0, likeNumber=77, createdTime=2021-12-25, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79a729266362, moduleTitle=Front Oncol：既往接受过抗血管治疗可能影响后线安罗替尼治疗晚期肺癌的PFS，但不影响OS和ORR, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=79a729266362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630960, encodeId=7f0a163096016, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=Amino Acids：口服营养补充剂可防止体重减轻并减少晚期肺癌化疗患者的副作用, objectType=article, longId=221291, objectId=8dac2212910f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dac2212910f, replyNumber=0, likeNumber=72, createdTime=2021-12-01, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dac2212910f, moduleTitle=Amino Acids：口服营养补充剂可防止体重减轻并减少晚期肺癌化疗患者的副作用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8dac2212910f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630959, encodeId=e4071630959a3, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, objectType=article, longId=221034, objectId=5e2522103406, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e2522103406, replyNumber=0, likeNumber=74, createdTime=2021-11-27, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e2522103406, moduleTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5e2522103406)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630958, encodeId=2b60163095830, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=晚期肺癌免疫联合抗血管生成治疗, objectType=article, longId=220783, objectId=b5b5220e831a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5b5220e831a, replyNumber=0, likeNumber=88, createdTime=2021-11-23, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5b5220e831a, moduleTitle=晚期肺癌免疫联合抗血管生成治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b5b5220e831a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630957, encodeId=0afb163095e6c, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=解毒复正汤联合EGFR-TKIs对老年晚期肺癌患者的临床疗效观察, objectType=article, longId=220637, objectId=011e22063e38, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=011e22063e38, replyNumber=0, likeNumber=74, createdTime=2021-11-21, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=011e22063e38, moduleTitle=解毒复正汤联合EGFR-TKIs对老年晚期肺癌患者的临床疗效观察, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=011e22063e38)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630956, encodeId=3e2e1630956ef, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=五脏相音”与“导引”理论在晚期肺癌患者临床心理护理的研究, objectType=article, longId=220630, objectId=bef52206302b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bef52206302b, replyNumber=0, likeNumber=82, createdTime=2021-11-21, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bef52206302b, moduleTitle=五脏相音”与“导引”理论在晚期肺癌患者临床心理护理的研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=bef52206302b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630955, encodeId=6471163095531, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=晚期肺癌免疫检查点抑制剂治疗的前景, objectType=article, longId=216881, objectId=3a6e216881b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a6e216881b8, replyNumber=0, likeNumber=0, createdTime=2021-09-11, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a6e216881b8, moduleTitle=晚期肺癌免疫检查点抑制剂治疗的前景, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3a6e216881b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630954, encodeId=035b163095420, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=Chest：晚期肺癌患者临终时姑息治疗与医疗资源使用和治疗质量的关联, objectType=article, longId=196493, objectId=44361964935b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44361964935b, replyNumber=0, likeNumber=68, createdTime=2020-06-27, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44361964935b, moduleTitle=Chest：晚期肺癌患者临终时姑息治疗与医疗资源使用和治疗质量的关联, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=44361964935b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630953, encodeId=a388163095358, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=李峻岭教授：从临床实践到研究进展，全面基因组测序为晚期肺癌患者争取更多治疗机会, objectType=article, longId=194535, objectId=59e61945352c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59e61945352c, replyNumber=0, likeNumber=60, createdTime=2020-05-23, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59e61945352c, moduleTitle=李峻岭教授：从临床实践到研究进展，全面基因组测序为晚期肺癌患者争取更多治疗机会, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=59e61945352c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630952, encodeId=40781630952b8, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=Amino Acids：口服营养补充剂可防止体重减轻并减少晚期肺癌化疗患者的副作用, objectType=article, longId=188441, objectId=02b0188441ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02b0188441ac, replyNumber=0, likeNumber=63, createdTime=2020-02-21, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b0188441ac, moduleTitle=Amino Acids：口服营养补充剂可防止体重减轻并减少晚期肺癌化疗患者的副作用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=02b0188441ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630951, encodeId=52be1630951c4, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, objectType=article, longId=187720, objectId=ddb118e72078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddb118e72078, replyNumber=0, likeNumber=80, createdTime=2020-02-10, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddb118e72078, moduleTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ddb118e72078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630950, encodeId=5ee31630950b7, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=Chest：阿瑞匹坦作为晚期肺癌的咳嗽抑制剂, objectType=article, longId=186501, objectId=bf29186501ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf29186501ad, replyNumber=0, likeNumber=70, createdTime=2020-01-20, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf29186501ad, moduleTitle=Chest：阿瑞匹坦作为晚期肺癌的咳嗽抑制剂, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=bf29186501ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630949, encodeId=73a31630949d5, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=JAMA Oncology：二甲双胍抗癌实锤！临床试验证实，二甲双胍+靶向药一线治疗，可将携带EGFR突变晚期肺癌患者的生存期延长14个月, objectType=article, longId=180022, objectId=5bda180022ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bda180022ac, replyNumber=0, likeNumber=69, createdTime=2019-09-26, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bda180022ac, moduleTitle=JAMA Oncology：二甲双胍抗癌实锤！临床试验证实，二甲双胍+靶向药一线治疗，可将携带EGFR突变晚期肺癌患者的生存期延长14个月, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5bda180022ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630948, encodeId=356b16309483b, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=怀上二胎却得了晚期肺癌：这个康复故事，临床数据永远不会告诉你, objectType=article, longId=178679, objectId=59951e8679da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59951e8679da, replyNumber=0, likeNumber=70, createdTime=2019-09-04, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59951e8679da, moduleTitle=怀上二胎却得了晚期肺癌：这个康复故事，临床数据永远不会告诉你, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=59951e8679da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630947, encodeId=7696163094e98, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=开启局部晚期肺癌治疗“新模式”——听吴一龙教授解读CTONG1103研究发现, objectType=article, longId=170144, objectId=32b91e014439, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32b91e014439, replyNumber=0, likeNumber=70, createdTime=2019-06-27, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32b91e014439, moduleTitle=开启局部晚期肺癌治疗“新模式”——听吴一龙教授解读CTONG1103研究发现, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=32b91e014439)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630946, encodeId=d916163094653, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=靶向治疗开启局部晚期肺癌治疗“新模式”，靶向-手术-靶向降低61%肺癌复发风险, objectType=article, longId=168748, objectId=b7aa168e4877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7aa168e4877, replyNumber=0, likeNumber=73, createdTime=2019-06-20, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7aa168e4877, moduleTitle=靶向治疗开启局部晚期肺癌治疗“新模式”，靶向-手术-靶向降低61%肺癌复发风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b7aa168e4877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1630945, encodeId=9cde16309451b, content=<a href='/topic/show?id=ca8259866b6' target=_blank style='color:#2F92EE;'>#晚期肺癌#</a>, objectTitle=J Clin Oncol:局部晚期肺癌新希望——JCO发表CTONG 1103靶向-手术-靶向多中心研究成果, objectType=article, longId=168698, objectId=ca0c168698eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca0c168698eb, replyNumber=0, likeNumber=81, createdTime=2019-06-20, rootId=0, userName=yangwen5716, userId=974321610743, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca0c168698eb, moduleTitle=J Clin Oncol:局部晚期肺癌新希望——JCO发表CTONG 1103靶向-手术-靶向多中心研究成果, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ca0c168698eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

晚期肺癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#非小细胞肺癌# #晚期肺癌#

European Radiology：预测晚期非小细胞肺癌患者消融后无进展生存的预后模型

2024-03-22发表于上海

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

【今晚直播】局部晚期肺癌基于分子分期和分子分型的“个体化”MDT治疗策略

2022-08-19

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

ASCO发布2022版肺癌诊治指南：晚期肺癌一线、二线、三线治疗全汇总！

2022-07-30

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

Front Oncol：既往接受过抗血管治疗可能影响后线安罗替尼治疗晚期肺癌的PFS，但不影响OS和ORR

2021-12-25

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

Amino Acids：口服营养补充剂可防止体重减轻并减少晚期肺癌化疗患者的副作用

2021-12-01

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关

2021-11-27

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

晚期肺癌免疫联合抗血管生成治疗

2021-11-23

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

解毒复正汤联合EGFR-TKIs对老年晚期肺癌患者的临床疗效观察

2021-11-21

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

五脏相音”与“导引”理论在晚期肺癌患者临床心理护理的研究

2021-11-21

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

晚期肺癌免疫检查点抑制剂治疗的前景

2021-09-11

仁医06 (审核中...)

前往app查看评论内容

#晚期肺癌#

Chest：晚期肺癌患者临终时姑息治疗与医疗资源使用和治疗质量的关联

2020-06-27

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

李峻岭教授：从临床实践到研究进展，全面基因组测序为晚期肺癌患者争取更多治疗机会

2020-05-23

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

Amino Acids：口服营养补充剂可防止体重减轻并减少晚期肺癌化疗患者的副作用

2020-02-21

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关

2020-02-10

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

Chest：阿瑞匹坦作为晚期肺癌的咳嗽抑制剂

2020-01-20

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

JAMA Oncology：二甲双胍抗癌实锤！临床试验证实，二甲双胍+靶向药一线治疗，可将携带EGFR突变晚期肺癌患者的生存期延长14个月

2019-09-26

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

怀上二胎却得了晚期肺癌：这个康复故事，临床数据永远不会告诉你

2019-09-04

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

开启局部晚期肺癌治疗“新模式”——听吴一龙教授解读CTONG1103研究发现

2019-06-27

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

靶向治疗开启局部晚期肺癌治疗“新模式”，靶向-手术-靶向降低61%肺癌复发风险

2019-06-20

yangwen5716 (审核中...)

前往app查看评论内容

#晚期肺癌#

J Clin Oncol:局部晚期肺癌新希望——JCO发表CTONG 1103靶向-手术-靶向多中心研究成果

2019-06-20

科室
- - 订阅+
  - 更多科室
工具
服务